223 studies found for:    nasopharyngeal cancer | "Nasopharyngeal Neoplasms"
Show Display Options
Rank Status Study
21 Unknown  Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer
Condition: Advanced Nasopharyngeal Cancer
Interventions: Drug: Nimotuzumab;   Drug: placebo plus chemoradiotherapy
22 Completed EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)
Conditions: Nasopharyngeal Cancer;   EBV Infections
Interventions: Biological: EBV specific CTL Infusion;   Biological: Anti CD45 monoclonal antibody
23 Completed
Has Results
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
Conditions: Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Biological: bevacizumab;   Drug: cisplatin;   Drug: fluorouracil
24 Not yet recruiting Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
Condition: Nasopharyngeal Carcinoma
Intervention:
25 Active, not recruiting A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal Cancer
Conditions: Colorectal Cancer;   Nasopharyngeal Cancer
Intervention: Procedure: Tumor biopsies
26 Recruiting Screening for Nasopharyngeal Carcinoma in High Risk Populations
Conditions: Nasopharyngeal Cancer;   Screening
Intervention:
27 Recruiting Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Conditions: Epstein-Barr Virus Infection;   Stage II Lymphoepithelioma of the Nasopharynx;   Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx
Interventions: Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Drug: fluorouracil;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Other: clinical observation;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
28 Active, not recruiting Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Conditions: Stage I Lymphoepithelioma of the Nasopharynx;   Stage I Squamous Cell Carcinoma of the Nasopharynx;   Stage II Lymphoepithelioma of the Nasopharynx;   Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx
Interventions: Drug: amifostine trihydrate;   Drug: fluorouracil;   Drug: cisplatin;   Other: laboratory biomarker analysis;   Radiation: radiation therapy
29 Completed Parotid-sparing IMRT for Nasopharyngeal Cancer
Conditions: Nasopharyngeal Cancers;   Intensity Modulated Radiotherapy With Chemotherapy
Intervention: Radiation: Intensity modulated radiotherapy with chemotherapy
30 Completed Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
Conditions: Recurrent Nasopharyngeal Cancer;   Stage IV Nasopharyngeal Cancer
Interventions: Drug: bortezomib;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis
31 Unknown  Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer
Condition: Nasopharyngeal Cancer
Intervention: Drug: Docetaxel, Cisplatin
32 Active, not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx
Interventions: Drug: azacitidine;   Drug: vorinostat;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Procedure: axillary lymph node biopsy
33 Completed Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount
Condition: Nasopharyngeal Carcinoma
Intervention:
34 Recruiting Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Icotinib;   Radiation: intensity-modulated radiotherapy;   Drug: Paclitaxel and Cisplatin;   Other: Quality of life;   Genetic: Epidermal growth factor receptor status
35 Recruiting A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Cancer;   Epstein Barr Virus Infections
Intervention: Drug: MVA-EBNA1/LMP2 vaccine
36 Completed T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC
Condition: Head and Neck Cancer
Intervention: Biological: autologous EBV specific CTLs
37 Terminated Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers
Condition: Nasopharyngeal Cancers
Intervention: Procedure: Induction chemotherapy + concurrent radiochemotherapy vs. concurrent radiochemotherapy
38 Unknown  Cisplatin and Radiation Therapy With or Without Gemcitabine Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced Nasopharyngeal Cancer
Condition: Head and Neck Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Radiation: intensity-modulated radiation therapy
39 Completed A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.
Condition: Nasopharyngeal Cancer
Interventions: Drug: capecitabine [Xeloda];   Drug: Oxaliplatin
40 Completed Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
Conditions: Head and Neck Cancer;   Oral Complications of Radiation Therapy;   Radiation Toxicity
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Procedure: adjuvant therapy;   Procedure: assessment of therapy complications;   Procedure: quality-of-life assessment;   Radiation: radiation therapy

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years